Management of infections associated with laser-assisted cosmetic skin resurfacing

Oral and Maxillofacial Surgery Clinics of North America

Volumn 15, Issue 1, 2003, Pages 147-153

  Strauss, Robert A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CEPHALOSPORIN; CIPROFLOXACIN; FAMCICLOVIR; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; PSEUDOMONIC ACID; VALACICLOVIR;

ANAMNESIS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTION; CLINICAL PROTOCOL; DRUG USE; ESTHETIC SURGERY; HERPES; HERPES SIMPLEX VIRUS; HUMAN; INCIDENCE; LASER SURGERY; LEGAL ASPECT; MYCOSIS; NONHUMAN; REVIEW; SCAR FORMATION; SKIN INFECTION; SKIN SURFACE; TREATMENT PLANNING; VIRUS INFECTION; WOUND DRESSING;

EID: 0037309420     PISSN: 10423699     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1042-3699(02)00081-X     Document Type: Review

References (34)

1. Fitzpatrick RE. Laser resurfacing of rhytides. Dermatol Clin 1997;15:431-47.
2. Gilchrest BA. Skin aging and photoaging. Dermatol Nurs 1990;2:79-84.
3. Gallis HA. Normal flora and opportunistic infections. In: Joklik WK, Willet HP, Amos DB, et al, editors. Zinsser microbiology. 19th edition. Norwalk (CT): Appleton and Lange; 1988. p. 337-42.
4. Schuster GS. Microbiology of the orofacial region. In: Topazian RG, Goldberg MH, Hupp JR, editors. Oral and maxillofacial infections. 4th edition. Philadelphia: W.B. Saunders Co.; 2002. p. 30-42.
5. Gaspar Z, Vincuillo C, Elliot T. Antibiotic prophylaxis for full face laser resurfacing: is it necessary? Arch Dermatol 2001;137:1251-2.
6. Manuskiatti W, Fitzpatrick RE, Goldman MP, et al. Prophylactic antibiotics in patients undergoing laser resurfacing of the skin. J Am Acad Dermatol 1999; 40:77-84.
7. Nanni CA, Alster TS. Complications of carbon dioxide laser resurfacing: an evaluation of 500 patients. Dermatol Surg 1998;24:315-20.
8. Sriprachya-Anunt S, Fitzpatrick RE, Goldman MP, et al. Infections complicating pulsed carbon dioxide laser resurfacing for photoaged facial skin. Dermatol Surg 1997;23:527-35.
9. 2 laser resurfacing infection rate with and without prophylactic antibiotics. Dermatol Surg 1999;25:857-61.
10. Weinstein C, Pozner JN, Ramirez OM. Complications of carbon dioxide laser resurfacing and their prevention. Aesthetic Surgery Journal 1997;17:216-22.
11. Futoryan T, Grande D. Postoperative wound infection rates in dermatologic surgery. Dermatol Surg 1995;21: 509-14.
12. Husain MT, Karim QN, Tajuri S. Analysis of infection in a burn wound. Burns 1989;15:299-302.
13. Ross EV, Amesbury EC, Barile A, et al. Incidence of postoperative infection or positive culture after facial laser resurfacing: a pilot study, a case report, and a proposal for rational approach to antibiotic prophylaxis. J Am Acad Dermatol 1998;39:975-81.
14. 2 laser resurfacing and occlusive dressing use. Dermatol Surg 2000;26:32-6.
15. Lawrence N, Coleman WP. Postoperative care after laser resurfacing. In: Coleman WP, Lawrence N, editors. Skin resurfacing. Baltimore: Williams and Wilkins; 1998. p. 189-95.
16. Newman JP, Fitzgerald P, Kock RJ. Review of closed dressing after laser resurfacing. Dermatol Surg 2000;26: 562-71.
17. Goldman MP. Pre- and postoperative care of the laser resurfacing patient. International Journal of Aesthetic and Restorative Surgery 1997;5:46-9.
18. Bellman B, Brandt FS, Holtmann M, et al. Infection with methicillin-resistant Staphylococcus aureus after carbon dioxide resurfacing of the face: successful treatment with minocycline, rifampin, and mucipirin ointment. Dermatol Surg 1998;24:279-82.
19. Kagan RJ, Naraqi S, Matsuda T, et al. Herpes simplex virus and cytomegalovirus infections in burned patients. J Trauma 1985;25:40-5.
20. Rappaport MJ, Kramer F. Exacerbation of facial herpes simplex after phenol facial peels. J Dermatol Surg Oncol 1984;10:57-8.
21. Perkins SW, Sklarew EC. Prevention of facial herpetic infections after chemical peel and dermabrasion: new treatment strategies in the prophylaxis of patients undergoing procedures of the perioral area. Plast Reconstr Surg 1996;98:427-33.
22. Farber GA. Chemical peeling in the treatment of certain cosmetic defects and diseases of the skin. In: Burks JW, editor. Dermabrasion and chemical peeling. Springfield (IL): Charles Thomas Publishing; 1979. p. 209-26.
23. Alster TS, Nanni CA. Famciclovir prophylaxis of herpes simplex virus reactivation after laser skin resurfacing. Dermatol Surg 1999;25:242-6.
24. Wall SH, Ramey SJ, Wall F. Famciclovir as antiviral prophylaxis in laser resurfacing procedures. Plast Reconstr Surg 1999;104:1103-8.
25. Gilbert S, McBurney E. Use of valacyclovir for herpes simplex virus-1 (HSV-1) prophylaxis after facial resurfacing: a randomized clinical trial of dosing regimens. Dermatol Surg 2000;1:50-4.
26. Rendon-Pellerano MI, Lentini J, Eaglestein WE, et al. Laser resurfacing: usual and unusual complications. Dermatol Surg 1999;5:360-6.
27. Kilmer SL. Laser resurfacing complications: how to treat them and avoid them. International Journal of Aesthetic and Restorative Surgery 1997;5:41-5.
28. Conn H, Nanda VS. Prophylactic fluconazole promotes reepithelialization in full-face carbon dioxide laser skin resurfacing. Lasers Surg Med 2000;26: 201-7.
29. Strauss RA, McMunn W, Gregory BA. Cosmetic skin resurfacing. Selected Readings in Oral and Maxillofacial Surgery 2001;9:1-32.
30. Friedman PM, Geronemus RG. Antibiotic prophylaxes in laser resurfacing patients. Dermatol Surg 2000;26: 695-6.
31. Kauvar ANB. Laser skin resurfacing: perspectives at the millennium. Dermatol Surg 2000;26:174-7.
32. Alster TS. Against antibiotic prophylaxis for cutaneous laser resurfacing. Dermatol Surg 2000;26:697-8.
33. Gaspar Z, Apfelberg DB. Summary of the 1997 ASAPRS/ASPRS laser task force survey on laser resurfacing and laser blepharoplasty. Plast Reconstr Surg 1998;101:511-8.
34. Waldorf HA, Kauvar ANB, Grossman MC, et al. Skin resurfacing of fine to deep rhytids using a char free carbon dioxide laser in 47 patients. Dermatol Surg 1995;21:940-6.